Sanger Heart & Vascular Institute, Atrium Health, treated the first patient with the new implantable medical device following FDA premarket approval Amsterdam, the Netherlands – Royal Philips (NYSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results